LYNORIQInsightsStart free

What changed in Omega Healthcare Investors, Inc.'s latest annual report

In the year ended 31 Dec 2025, Omega Healthcare Investors, Inc.'s revenue rose 13.2% to USD 1.19bn, from USD 1.05bn; net income rose 45.2% to USD 590.18m, from USD 406.33m; cash and cash equivalents fell 94.8% to USD 27.02m, from USD 518.34m.

Year ended 31 Dec 2025. Source: 10-K filed 9 Feb 2026, read it on SEC EDGAR.

USD 1.05bn to USD 1.19bn

Revenue, up 13.2% year on year

The figures, year on year

Annual figures as reported to the SEC, in US dollars. Changes are calculated from the two values.
ItemYear beforeLatest yearChange
Revenue1.05bn1.19bnUp 13.2%
Net income406.33m590.18mUp 45.2%
Total assets9.90bn10.05bnUp 1.5%
Total liabilities5.17bn4.61bnDown 10.8%
Long-term debt4.84bn4.26bnDown 12%
Cash and cash equivalents518.34m27.02mDown 94.8%
Shareholders' equity4.54bn5.18bnUp 14.2%

Questions people ask

Did Omega Healthcare Investors, Inc.'s revenue grow last year?

Revenue grew 13.2%, from USD 1.05bn to USD 1.19bn in the year ended 31 Dec 2025.

Is Omega Healthcare Investors, Inc. profitable?

Yes. Net income was USD 590.18m in the year ended 31 Dec 2025. The year before: USD 406.33m.

How much cash and debt does Omega Healthcare Investors, Inc. have?

At its latest year end (31 Dec 2025), Omega Healthcare Investors, Inc. reported cash and cash equivalents of USD 27.02m and long-term debt of USD 4.26bn.

Where do these numbers come from?

From Omega Healthcare Investors, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.

Meeting a client who works with Omega Healthcare Investors, Inc.?

LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.

Start free See the demo

Other Real Estate Investment Trusts companies

Omega Healthcare Investors, Inc. (OHI) 10-K: what changed year on year | LYNORIQ Insights